Testing remote 5G cloud checks for patients with heart implanted devices
Compares 5G cloud follow-up with routine visits in adults with heart implanted devices.
Plain-language title generated from the registry record
Registry title: Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices
Key facts
- Where
- Chengdu and Guangzhou, ChinaSee the 2 sites
Where in China
- The Third People's Hospital of ChengduChengdu, ChinaTaking people
- Sun Yat-sen Memorial HospitalGuangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Third People's Hospital of Chengdu
- Trial code
- NCT06652750
- Record updated
- 21 November 2024
- Original description
Objective: This clinical study employs a prospective, paired, self-controlled, non-inferiority, multicenter research design to assess the safety and efficacy of utilizing 5G cloud follow-up for CIED in parameters monitoring and remote programming post-implantation.Read full original descriptionShow less
Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices: a Prospective, Paired, Self-controlled, Non-inferiority, Multicenter Clinical Trial
Objective: This clinical study employs a prospective, paired, self-controlled, non-inferiority, multicenter research design to assess the safety and efficacy of utilizing 5G cloud follow-up for CIED in parameters monitoring and remote programming post-implantation.
Participants will:
undergo regular clinic follow-up visits in accordance with the guidelines undergo routine in-office follow-up and 5G cloud follow-up during each regular clinic visit
Inclusion: Age ≥ 18 years, gender unspecified; Patients who have not undergone their first clinic follow-up after the implantation of cardiovascular implantable electronic devices (CIED); Note: In this study, CIED includes pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy pacemakers (CRT-P) and defibrillators (CRT-D), excluding implantable cardiac event recorders (ICM) and implantable cardiovascular monitors; Willing to participate in this clinical study and have signed the informed consent form in writing.
Exclusion: Participated in other clinical studies within 30 days before enrollment. Other situations that the researcher deems unsuitable for inclusion; Inability to cooperate with treatment or follow-up, such as having mental illness; Exclusion Criteria:; If meeting any of the following, the individual cannot be included:; Life expectancy < 1 year.